MALVERN, Pa., October 26, 2023 — LifeSensors, Inc., a leading innovator in protein degradation technologies, has been invited to speak at the 6th Annual Targeted Protein Degradation Summit 2023 in Boston, Massachusetts. The event will take place from October 30-November 2 at Westin Copley Place, Boston. LifeSensors will be exhibiting, and Dr. Karteek Kadimisetty will deliver an insightful presentation on novel PROTAC and Molecular Glue technologies.
Proteins play a critical role in various cellular processes, and targeted protein degradation has emerged as a revolutionary approach for the development of therapeutics in numerous disease areas, including cancer and neurodegenerative disorders. LifeSensors has been at the forefront of this field, and the company is excited to share its latest advancements in PROTAC (Proteolysis Targeting Chimeras) and Molecular Glue technologies at the summit. Current methods for discovering novel ligands for targeted protein ubiquitination are inefficient, cumbersome, or prone to artifacts. Dr. Kadimisetty will elaborate on a cutting-edge platform developed by LifeSensors, which offers a direct means of quantifying ubiquitination mediated by PROTACs or molecular glue for specific target proteins.
LifeSensors invites all summit attendees to visit their booth at the exhibition area, where they can learn more about the company’s products and solutions, as well as engage with LifeSensors’ team members for in-depth discussions.
About LifeSensors
LifeSensors. Inc. partners with pharma and biotech companies and helps life scientists innovate in basic research, drug discovery and diagnostics. We pioneered the SUMO-fusion system for high quality protein expression. Our development of cutting-edge tools for the ubiquitin proteasome system (UPS) and Protein Targeting Chimers (PROTAC) allow scientists new ways to observe and discover the fundamentals of this emerging area in medicine. Poly-ubiquitin affinity matrices, Tandem Ubiquitin Binding Entities (TUBES), are changing the way scientists make discoveries in UPS and identify novel biomarkers for neurodegeneration and drug discovery. We are making an impact in the lives of scientists through innovation and pushing the envelope with regards to novel research techniques not only in PROTACs but in the growing and highly applicable areas of Molecular Glues and other technology regarding the ubiquitin proteasome system.
Contact: Isabelle Wentzel
Business Development
LifeSensors, Inc.
bd@lifesensors.com
(610) 644-8845 EXT. 304